MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$34,495,505
EPS
-$0.74
Unit: Dollar

Income Statement
2025-12-31
Research and development expenses
19,025,832
General and administrative expenses
12,518,127
Total operating expenses
31,543,959
Loss from operations
-31,543,959
Interest income
1,217,241
Interest expense
5,338,607
Interest income (expenses), net
-4,121,366
Loss before income taxes
-35,665,325
Benefit for income taxes
-1,169,820
Net loss
-34,495,505
Basic EPS
-0.74
Diluted EPS
-0.74
Basic Average Shares
46,384,280
Diluted Average Shares
46,384,280
Unit: Dollar.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$34,495,505 Benefit for income taxes-$1,169,820 Loss before incometaxes-$35,665,325 Loss from operations-$31,543,959 Interest income(expenses), net-$4,121,366 Interest income$1,217,241 Total operatingexpenses$31,543,959 Interest expense$5,338,607 Research and developmentexpenses$19,025,832 General andadministrative expenses$12,518,127

PDS Biotechnology Corp (PDSB)

PDS Biotechnology Corp (PDSB)